Teva Pharmaceutical Industries

Experts have expressed divided opinions after the Croatian Bureau of Statistics reported that the volume of the industrial production in December 2016 was 14.9 per cent higher than 12 months earlier.

The figure represents the biggest annual growth since 2001, when such statistics were made for the first time by the Bureau, as well as a rise of four per cent on November 2016.

U.S. drug maker Pfizer Inc and Ireland-based Allergan Plc formally announced the scrapping of their $160 billion merger on April 6, in a big win for President Barack Obama who has been pushing to curb tax-slashing "inversion" deals.

Israeli pharmaceutical giant Teva said on July 27 that it was buying the generic drug business of Allergan for $40.5 billion, consolidating its position as a world leader in generics.

Teva will pay $33.75 billion in cash and offer $6.75 billion of its stock to Allergan, the company said, in a major move that will further shake up the industry.